Perma-Pipe International (PPIH) 10-Q 21 Dec 20 2020 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Oct. 31, 2020	Dec. 18, 2020
Document Information [Line Items]
Entity Registrant Name	Perma-Pipe International Holdings, Inc.
Entity Central Index Key	0000914122
Trading Symbol	ppih
Current Fiscal Year End Date	--01-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding (in shares)		8,164,989
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Oct. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false
Title of 12(b) Security	Common Stock, $.01 par value per share

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Net sales	$ 20,294	$ 34,457	$ 63,399	$ 95,400
Cost of sales	17,356	26,814	54,630	73,382
Gross profit	2,938	7,643	8,769	22,018
Operating expenses
General and administrative expenses	4,528	4,636	13,320	13,907
Selling expenses	1,174	1,354	4,153	4,030
Total operating expenses	5,702	5,990	17,473	17,937
Income/(loss) from operations	(2,764)	1,653	(8,704)	4,081
Interest expense, net	107	194	411	612
Other income/(expense)	(2)	95	3,672	351
Income/(loss) from operations before income taxes	(2,873)	1,554	(5,443)	3,820
Income tax (benefit)/expense	(23)	1,699	(339)	1,747
Net income/(loss)	$ (2,850)	$ (145)	$ (5,104)	$ 2,073
Weighted average common shares outstanding
Basic (in shares)	8,165	8,037	8,113	7,970
Diluted (in shares)	8,165	8,037	8,113	8,272
Income/(loss) per share
Basic (in dollars per share)	$ (0.35)	$ (0.02)	$ (0.63)	$ 0.26
Diluted (in dollars per share)	$ (0.35)	$ (0.02)	$ (0.63)	$ 0.25

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Net income/(loss)	$ (2,850)	$ (145)	$ (5,104)	$ 2,073
Other comprehensive income/(loss)
Foreign currency translation adjustments, net of tax	110	12	(104)	53
Other comprehensive income/(loss)	110	12	(104)	53
Comprehensive income/(loss)	$ (2,740)	$ (133)	$ (5,208)	$ 2,126

Consolidated Balance Sheets (Cu

Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Current assets
Cash and cash equivalents	$ 6,593	$ 13,371
Restricted cash	1,154	1,287
Trade accounts receivable, less allowance for doubtful accounts of $411 at October 31, 2020 and $407 at January 31, 2020	26,441	29,402
Inventories, net	12,094	14,498
Prepaid expenses and other current assets	5,022	3,531
Costs and estimated earnings in excess of billings on uncompleted contracts	1,362	2,166
Total current assets	52,666	64,255
Property, plant and equipment, net of accumulated depreciation	26,958	28,629
Other assets
Operating lease right-of-use asset	13,762	11,475
Deferred tax assets	604	293
Goodwill	2,237	2,254
Other assets	3,532	5,319
Total other assets	20,135	19,341
Total assets	99,759	112,225
Current liabilities
Trade accounts payable	7,905	9,577
Accrued compensation and payroll taxes	1,760	1,190
Commissions and management incentives payable	322	1,759
Revolving line - North America	1,803	8,577
Current maturities of long-term debt	1,732	1,458
Customers' deposits	2,098	2,202
Outside commission liability	1,661	1,755
Operating lease liability short-term	1,408	1,040
Other accrued liabilities	3,002	3,444
Billings in excess of costs and estimated earnings on uncompleted contracts	672	1,173
Income taxes payable	1,000	664
Total current liabilities	23,363	32,839
Long-term liabilities
Long-term debt, less current maturities	6,194	6,717
Deferred compensation liabilities	4,487	4,199
Deferred tax liabilities	583	1,052
Operating lease liability long-term	13,477	11,214
Other long-term liabilities	661	575
Total long-term liabilities	25,402	23,757
Stockholders' equity
Common stock, $.01 par value, authorized 50,000 shares; 8,165 issued and outstanding at October 31, 2020 and 8,048 issued and outstanding at January 31, 2020	82	80
Additional paid-in capital	60,595	60,024
Accumulated deficit	(5,819)	(715)
Accumulated other comprehensive loss	(3,864)	(3,760)
Total stockholders' equity	50,994	55,629
Total liabilities and stockholders' equity	$ 99,759	$ 112,225

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) shares in Thousands, $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Allowance for doubtful accoutns	$ 411	$ 407
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	50,000	50,000
Common stock, issued (in shares)	8,165	8,048
Common stock, outstanding (in shares)	8,165	8,048

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Stockholders' equity at Jan. 31, 2019	$ 79	$ 58,793	$ (4,291)	$ (2,880)	$ 51,701
Net income (loss)			(1,502)		(1,502)
Common stock issued under stock plans, net of shares used for tax withholding		79			79
Stock-based compensation expense		154			154
Foreign currency translation adjustment				(317)	(317)
Stockholder's equity at Apr. 30, 2019	$ 79	59,026	(5,793)	(3,197)	50,115
Balances at beginning of year (in shares) at Jan. 31, 2019	7,854,322
Stockholders' equity at Jan. 31, 2019	$ 79	58,793	(4,291)	(2,880)	51,701
Net income (loss)					2,073
Stockholder's equity at Oct. 31, 2019	$ 80	59,754	(2,218)	(2,827)	54,789
Balances at beginning of year (in shares) at Jan. 31, 2019	7,854,322
Shares issued (in shares)	193,684
Balances at period end (in shares) at Oct. 31, 2019	8,048,006
Stockholders' equity at Apr. 30, 2019	$ 79	59,026	(5,793)	(3,197)	50,115
Net income (loss)			3,720		3,720
Common stock issued under stock plans, net of shares used for tax withholding	1	43			44
Stock-based compensation expense		406			406
Foreign currency translation adjustment				358	358
Stockholder's equity at Jul. 31, 2019	80	59,475	(2,073)	(2,839)	54,643
Net income (loss)			(145)		(145)
Common stock issued under stock plans, net of shares used for tax withholding		53			53
Stock-based compensation expense		226			226
Foreign currency translation adjustment				12	12
Stockholder's equity at Oct. 31, 2019	$ 80	59,754	(2,218)	(2,827)	54,789
Balances at period end (in shares) at Oct. 31, 2019	8,048,006
Stockholders' equity at Jan. 31, 2020	$ 80	60,024	(715)	(3,760)	55,629
Net income (loss)			(2,521)		(2,521)
Stock-based compensation expense		219			219
Foreign currency translation adjustment				(367)	(367)
Stockholder's equity at Apr. 30, 2020	$ 80	60,243	(3,236)	(4,127)	52,960
Balances at beginning of year (in shares) at Jan. 31, 2020	8,048,006
Stockholders' equity at Jan. 31, 2020	$ 80	60,024	(715)	(3,760)	55,629
Net income (loss)					(5,104)
Stockholder's equity at Oct. 31, 2020	$ 82	60,595	(5,819)	(3,864)	50,994
Balances at beginning of year (in shares) at Jan. 31, 2020	8,048,006
Shares issued (in shares)	116,983
Balances at period end (in shares) at Oct. 31, 2020	8,164,989
Stockholders' equity at Apr. 30, 2020	$ 80	60,243	(3,236)	(4,127)	52,960
Net income (loss)			267		267
Common stock issued under stock plans, net of shares used for tax withholding	2	(193)			(191)
Stock-based compensation expense		260			260
Foreign currency translation adjustment				153	153
Stockholder's equity at Jul. 31, 2020	82	60,310	(2,969)	(3,974)	53,449
Net income (loss)			(2,850)		(2,850)
Stock-based compensation expense		285			285
Foreign currency translation adjustment				110	110
Stockholder's equity at Oct. 31, 2020	$ 82	$ 60,595	$ (5,819)	$ (3,864)	$ 50,994
Balances at period end (in shares) at Oct. 31, 2020	8,164,989

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Operating activities
Net income/(loss)	$ (5,104)	$ 2,073
Adjustments to reconcile net income/(loss) to net cash flows provided by operating activities
Depreciation and amortization	3,616	3,349
Deferred tax benefit	(763)	(288)
Equity-based compensation expense	764	786
(Gain)/loss on disposal of fixed assets	(2)	154
Provision on uncollectible accounts	6	49
Changes in operating assets and liabilities
Accounts receivable	1,226	2,960
Inventories	2,383	(3,980)
Contract assets and contract liabilities	302	(2,929)
Accounts payable	(1,606)	525
Accrued compensation and payroll taxes	(1,087)	(199)
Customers' deposits	(107)	(704)
Income taxes receivable and payable	102	80
Prepaid expenses and other current assets	(1,518)	1,523
Other assets and liabilities	3,757	(601)
Net cash provided by operating activities	1,969	2,798
Investing activities
Capital expenditures	(1,633)	(1,423)
Proceeds from sales of property and equipment	2
Net cash used in investing activities	(1,631)	(1,423)
Financing activities
Proceeds from loans	36,563	61,281
Payments of debt on revolving lines of credit	(42,988)	(61,613)
Proceeds from term loan	19
Payments of other debt	(269)	(276)
Decrease in drafts payable	(49)	(162)
Payments on finance lease obligations	(310)	(185)
Stock options exercised and restricted shares retired for tax	(192)	176
Net cash used in financing activities	(7,226)	(779)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(23)	26
Net increase/(decrease) in cash, cash equivalents and restricted cash	(6,911)	622
Cash, cash equivalents and restricted cash - beginning of period	14,658	12,737
Cash, cash equivalents and restricted cash - end of period	7,747	13,359
Supplemental cash flow information
Interest paid	421	609
Income taxes paid	83	1,961
Fixed assets acquired under capital leases - non-cash		$ 848

Note 1 - Basis of Presentation

Note 1 - Basis of Presentation	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1 The interim consolidated financial statements of Perma-Pipe International Holdings, Inc., and subsidiaries (collectively, "PPIH", "Company", or "Registrant") are unaudited, but include all adjustments that the Company's management considers necessary to present fairly the financial position and results of operations for the periods presented. These adjustments consist of normal recurring adjustments. Information and footnote disclosures have been omitted pursuant to Securities and Exchange Commission ("SEC") rules and regulations. The consolidated balance sheet as of January 31, 2020 not 10 January 31. 2020 2019 three nine October 31, 2020 2019 January 31, 2021 2020

Note 2 - Business Segment Repor

Note 2 - Business Segment Reporting	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	Note 2 The Company is engaged in the manufacture and sale of products in one may

Note 3 - Accounts Receivable

Note 3 - Accounts Receivable	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	Note 3 The majority of the Company's accounts receivable are due from geographically dispersed contractors and manufacturing companies. Credit is extended based on an evaluation of a customer's financial condition, including the availability of credit insurance. In the U.S., collateral is not may One of the Company's accounts receivable in the total amount of $ 3.9 $4.1 October 31, 2020 January 31, 2020 3.4 $1.6 2.1 as of October 31, 2020 January 31, 2020 2015 not first 2020, $0.5 third 2020, $0.2 fourth 2020 2021. 2019 not October 31, 2020 not may For the three October 31, 2020 no 10% 2019, one 16% nine October 31, 2020 no 10% 2019, one 11% At October 31, 2020 January 31, 2020 one 10.1% 13.3%

Note 4 - Revenue Recognition

Note 4 - Revenue Recognition	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	Note 4 Revenue from contracts with customers: The Company defines a contract as an agreement that has approval and commitment from both parties, defined rights and identifiable payment terms, which ensures the contract has commercial substance and that collectability is reasonably assured. The Company's standard revenue transactions are classified into two 1 Systems - which include all bundled products in which the Company designs, engineers, and manufactures pre-insulated specialty piping systems, insulates subsea flowline pipe, subsea oil production equipment, and land-lines. Additionally, this systems classification also includes coating applied to pipes and structures. 2 Products - which include cables, leak detection products, heat trace products sold under the PermAlert brand name, material/goods not not In accordance with Accounting Standards Codification ("ASC") 606 10 25 27 29, one 1 the customer owns the material that is being insulated or coated, so the customer controls the asset and thus the work-in-process; or 2 the customer controls the work-in-process due to the custom nature of the pre-insulated, fabricated system being manufactured as evidenced by the Company's right to payment for work performed to date plus seller's profit margin for products that have no Products revenue is recognized when goods are shipped or services are performed (ASC 606 10 25 30 A breakdown of the Company's revenues by revenue class for the three nine October 31, 2020 2019 Three Months Ended October 31, Nine Months Ended October 31, 2020 2019 2020 2019 Sales % to Total Sales % to Total Sales % to Total Sales % to Total Products $ 2,435 12 % $ 2,448 7 % $ 8,603 14 % $ 13,205 14 % Specialty Piping Systems and Coating Revenue recognized under input method 8,252 41 % 14,363 42 % 26,597 42 % 38,601 40 % Revenue recognized under output method 9,607 47 % 17,646 51 % 28,199 44 % 43,594 46 % Total $ 20,294 100 % $ 34,457 100 % $ 63,399 100 % $ 95,400 100 % The input method, as noted in ASC 606 10 55 20, The output method, as noted in ASC 606 10 55 17, may Some of the Company's operating entities invoice and collect milestones or other contractual obligations prior to the transfer of goods and services, but do not Contract modifications that occur prior to the start of the manufacturing process will supersede the original contract and revenue is recognized using the modified contract value. Contract modifications that occur during the manufacturing process (changes in scope of work, job performance, material costs, and/or final contract settlements) are recognized in the period in which the revisions are known. Provisions for losses on uncompleted contracts are made in contract liabilities account in the period such losses are identified. Contract assets and liabilities: Contract assets represent revenue recognized in excess of amounts billed (unbilled receivables) for contract work in progress for which the Company has a valid contract and an enforceable right to payment for work completed. Contract liabilities represent billings in excess of costs (unearned revenue) for contract work in progress for which the Company has a valid contract and an enforceable right to payment for work completed. Both customer billings and the satisfaction (or partial satisfaction) of the performance obligation(s) occur throughout the manufacturing process and impacts the period end balances in these accounts. The Company anticipates that substantially all costs incurred for uncompleted contracts as of October 31, 2020 one During the three October 31, 2020, one one $0.6 The following tables set forth the changes in the Company's contract assets and liabilities for the periods indicated. In addition to these amounts, the Company has recorded $1.4 October 31, 2020 Contract Assets Balance January 31, 2019 $ 1,653 Costs and gross profit recognized during the period for uncompleted contracts from the prior period (1,038 ) Costs and deferred gross profit incurred on uncompleted contracts not billed at the end of the current period 1,368 Closing Balance at April 30, 2019 $ 1,983 Costs and gross profit recognized during the period for uncompleted contracts from the prior period (1,509 ) Costs and deferred gross profit incurred on uncompleted contracts not billed at the end of the current period 3,000 Closing Balance at July 31, 2019 $ 3,474 Costs and gross profit recognized during the period for uncompleted contracts from the prior period (1,799 ) Costs and deferred gross profit incurred on uncompleted contracts not billed at the end of the current period 2,688 Closing Balance at October 31, 2019 $ 4,363 Balance January 31, 2020 $ 2,166 Costs and gross profit recognized during the period for uncompleted contracts from the prior period (2,896 ) Costs and deferred gross profit incurred on uncompleted contracts not billed at the end of the current period 3,630 Closing Balance at April 30, 2020 $ 2,900 Costs and gross profit recognized during the period for uncompleted contracts from the prior period (1,743 ) Costs and deferred gross profit incurred on uncompleted contracts not billed at the end of the current period 593 Closing Balance at July 31, 2020 $ 1,750 Costs and gross profit recognized during the period for uncompleted contracts from the prior period (930 ) Costs and deferred gross profit incurred on uncompleted contracts not billed at the end of the current period 542 Closing Balance at October 31, 2020 $ 1,362 Contract Liabilities Balance January 31, 2019 $ 1,569 Revenue recognized during the period for uncompleted contracts from the prior period (444 ) New contracts entered into that are uncompleted at the end of the current period 721 Closing Balance at April 30, 2019 $ 1,846 Revenue recognized during the period for uncompleted contracts from the prior period (1,250 ) New contracts entered into that are uncompleted at the end of the current period 545 Closing Balance at July 31, 2019 $ 1,141 Revenue recognized during the period for uncompleted contracts from the prior period (774 ) New contracts entered into that are uncompleted at the end of the current period 984 Closing Balance at October 31, 2019 $ 1,351 Balance January 31, 2020 $ 1,173 Revenue recognized during the period for uncompleted contracts from the prior period (17 ) New contracts entered into that are uncompleted at the end of the current period (95 ) Closing Balance at April 30, 2020 $ 1,061 Revenue recognized during the period for uncompleted contracts from the prior period 631 New contracts entered into that are uncompleted at the end of the current period (925 ) Closing Balance at July 31, 2020 $ 767 Revenue recognized during the period for uncompleted contracts from the prior period 104 New contracts entered into that are uncompleted at the end of the current period (199 ) Closing Balance at October 31, 2020 $ 672 Practical expedients: Costs to obtain a contract are not not one As the Company's contracts are less than one

Note 5 - Income Taxes

Note 5 - Income Taxes	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 5 The determination of the consolidated provision for income taxes, deferred tax assets and liabilities and related valuation allowances requires management to make judgments and estimates. As a company with subsidiaries in foreign jurisdictions, the process of calculating income taxes involves estimating current tax obligations and exposures in each jurisdiction as well as making judgments regarding the future recoverability of deferred tax assets. Income earned in the United Arab Emirates is not The Company's effective tax rate ("ETR") from operations in the third 2020 0.8% 6.2% 127.8% 48.6% The amount of unrecognized tax benefits, including interest and penalties at October 31, 2020 $0.1 On March 7, 2020, 748 100% no

Note 6 - Impairment of Long-liv

Note 6 - Impairment of Long-lived Assets	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Asset Impairment Charges [Text Block]	Note 6 The Company's assessment of long-lived assets, and other identifiable intangibles is based upon factors that market participants would use in accordance with the accounting guidance for the fair value measurement of assets. At October 31, 2020 not three not no three nine October 31, 2020 2019 Goodwill. as of October 31, 2020 January 31, 2020 2016. January 31, 2020 Foreign exchange change effect October 31, 2020 Goodwill $ 2,254 $ (17 ) $ 2,237 The Company performs an impairment assessment of goodwill annually as of January 31, October 31, 2020 0 not 1 1 1 no three nine October 31, 2020 2019 no not

Note 7 - Stock-based Compensati

Note 7 - Stock-based Compensation	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Share-based Payment Arrangement [Text Block]	Note 7 The Company's 2017 June 13, 2017, June 2017 ( "2017 June 2020. 2017 The Company has prior incentive plans under which previously granted awards remain outstanding, but under which no may October 31, 2020 529,570 While the 2017 422 2017 2017 The Company has granted stock-based compensation awards to eligible employees, officers or independent directors. The following were the Company's stock-based compensation expenses for the periods presented: Three Months Ended October 31, Nine Months Ended October 31, 2020 2019 2020 2019 Stock-based compensation expense $ - $ 2 $ 3 $ 10 Restricted stock-based compensation expense 285 224 761 776 Total stock-based compensation expense $ 285 $ 226 $ 764 $ 786 Stock Options The Company did not three nine October 31, 2020 Option activity No. of Shares Underlying Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 31, 2020 132 $ 8.98 3.2 $ 160 Expired or forfeited (18 ) - - - Outstanding at October 31, 2020 114 9.20 2.6 - Exercisable at October 31, 2020 114 $ 9.20 2.6 $ - No nine October 31, 2020 Unvested option activity No. of Shares Underlying Options Weighted Average Grant Date Fair Value Aggregate Intrinsic Value Outstanding at January 31, 2020 3 $ 7.33 $ 4 Vested (3 ) - - Expired or forfeited - - - Outstanding at October 31, 2020 - $ - $ - As of October 31, 2020 no no Restricted stock The following table summarizes the Company's restricted stock activity for the nine October 31, 2020 Restricted stock activity Restricted Shares Weighted Average Grant Price Per Share Aggregate Intrinsic Value Outstanding at January 31, 2020 321 $ 8.89 $ 2,857 Granted 156 5.88 Vested and issued (63 ) 8.96 Forfeited or retired for taxes (38 ) 8.20 Outstanding at October 31, 2020 376 $ 7.61 $ 2,857 As of October 31, 2020 $1.6 2017 1.9

Note 8 - Income_(Loss) Per Shar

Note 8 - Income/(Loss) Per Share	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Earnings Per Share [Text Block]	Note 8 Three Months Ended October 31, Nine Months Ended October 31, 2020 2019 2020 2019 Basic weighted average common shares outstanding 8,165 8,037 8,113 7,970 Dilutive effect of equity compensation plans - - - 302 Weighted average common shares outstanding assuming full dilution 8,165 8,037 8,113 8,272 Stock options and restricted stock not included in the computation of diluted earnings per share of common stock because the option exercise prices or grant date prices exceeded the average market prices of the common shares 227 83 223 68 Stock options and restricted stock with exercise prices or grant date prices below the average market prices 165 287 169 302

Note 9 - Debt

Note 9 - Debt	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 9 Debt totaled $ 9.7 $16.9 October 31, 2020 January 31, 2020 Paycheck Protection Program Loan. May 1, 2020, $3.2 1.0%, April 28, 2022. 1106 three July 31, 2020, 100% Guidance from the American Institute of Certified Public Accountants' ("AICPA") Technical Question and Answer Section 3200.18 may 20 no nine October 31, 2020 The IAS 20 nine October 31, 2020 Revolving lines - North America . September 20, 2018, three $18 The Company has used proceeds from the Senior Credit Facility for on-going working capital needs, and expects to continue using this facility to fund future capital expenditures, working capital needs and other corporate purposes. Borrowings under the Senior Credit Facility bear interest at a rate equal to an alternate base rate or London Interbank Offered Rate ("LIBOR"), plus, in each case, an applicable margin. The applicable margin is based on average quarterly undrawn availability with respect to the Senior Credit Facility. Interest on alternate base rate borrowings are generally payable monthly in arrears and interest on LIBOR borrowings are generally payable in arrears on the last day of each interest period. Additionally, the Company is required to pay a 0.375% Subject to certain exceptions, borrowings under the Senior Credit Facility are secured by substantially all of the assets of the Company and certain of the assets of its North American subsidiaries. The North American Loan Parties' obligations under the Senior Credit Facility are guaranteed by Perma-Pipe Canada, Inc. The Senior Credit Facility will mature on September 20, 2021. $3.0 The Senior Credit Facility also contains financial covenants requiring (i) the North America Loan Parties to achieve a ratio of its EBITDA (with certain additional adjustments) to the sum of scheduled cash principal payments on indebtedness for borrowed money and interest payments on the advances under the Senior Credit Facility (excluding from the calculation items related to the financial performance of the Company's foreign subsidiaries not not 1.10 1.00 four not not 1.10 1.00 four As of October 31, 2020, 1.10 1.00 four October 31, 2020 October 31, 2020 On December 17, 2020, 1.10 1.00 October 31, 2020 four $1 one December 17, 2020 not $0.2 $2.0 The amended fixed charge coverage ratio requirements for the Company and its subsidiaries under the Amendment and Waiver are (i) 1.25 1.00 six April 30, 2021 1.25 1.00 nine July 31, 2021. 1.10 1.00 three January 31, 2021; ( 1.10 1.00 six April 30, 2021; 1.10 1.00 nine July 31, 2021. may not October 31, 2020, not $6.2 not The Company believes it has alleviated any concerns about its ability to satisfy its obligations in the normal course of business for the next year after the date these financial statements are available to be issued based on the following: ● The Company's execution of the Amendment and Waiver described above, ● The Company's ability to repatriate cash from its foreign subsidiaries to cure any future covenant defaults without any material cost or tax consequences, ● The Company expects an increase in business activity and cash flow from operations over the remaining term of the Amendment and Waiver, ● Management expects to be able to borrow within the reduced availability parameters noted above, and ● The Company's planned capital expenditures have some flexibility in the timing of the spend, allowing the Company to defer cash spending if necessary to aid compliance with loan covenants in the future. As of October 31, 2020 $1.8 6.25% 4.15% 5.09% $5.8 $2.0 Revolving lines - foreign . The Company has a revolving line for 8.0 $2.2 October 31, 2020 3.7% November 2020, December 2020 The Company has a second 19.5 $5.3 October 31, 2020 4.2% July 2020, December 2020 These credit arrangements are in the form of overdraft facilities and project financing at rates competitive in the countries in which the Company operates. The lines are secured by certain equipment, certain assets (such as accounts receivable and inventory), and a guarantee by the Company. Some credit arrangement covenants require a minimum tangible net worth to be maintained, including maintaining certain levels of intercompany subordinated debt. In addition, some of the revolving credit facilities restrict payment of dividends or undertaking of additional debt. In November 2019, 200.0 $12.7 October 31, 2020 11.6% June 2020, January 2021 The Company's credit arrangements used by its Middle Eastern subsidiaries renew on an annual basis. The Company guarantees the subsidiaries' debt including all foreign debt. The Company was in compliance with the covenants under the credit arrangements in the U.A.E. and Egypt as of October 31, 2020 October 31, 2020 3.0% 3.5% 4.5% 1.5% October 31, 2020 3.7% 11.6%, 3.88%, $20.2 October 31, 2020 $4.5 October 31, 2020 $1.0 $14.7 as of October 31, 2020 January 31, 2020 Mortgages. July 28, 2016, 8.0 $6.1 December 23, 2042. 4.55% October 31, 2020 January 2018. On June 19, 2012, $1.8 4.5% $13 July 1, 2027. June 19, 2022, not 2.0% 18.0% 4.5%.

Note 10 - Leases

Note 10 - Leases	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Lessee, Operating and Finance Leases [Text Block]	Note 10 Operating Leases. August 2020, 1.2 $0.3 October 31, 2020), August 2022. August 2050. Finance Leases. 2019, two 1.1 $0.8 8.0% $0.1 August 2023. 2017, three 1.1 $0.8 4.0% 7.8% $0.1 April 2021 September 2022. In August 2016, 0.6 $8 15.6% $1 July 2019. The Company has several significant operating lease agreements, with lease terms of one 14 not not not not one At October 31, 2020 $14.9 $13.8 October 31, 2020 0.8 1.0 Supplemental balance sheet information related to leases is as follows: Operating and Finance leases: October 31, 2020 January 31, 2020 Finance leases assets: Property and Equipment - gross $ 1,683 $ 1,696 Accumulated depreciation and amortization (700 ) (551 ) Property and Equipment - net $ 983 $ 1,145 Finance lease liabilities: Finance lease liability short-term $ 333 $ 417 Finance lease liability long-term 446 677 Total finance lease liabilities $ 779 $ 1,094 Operating lease assets: Operating lease ROU assets $ 13,762 $ 11,475 Operating lease liabilities: Operating lease liability short-term $ 1,408 $ 1,040 Operating lease liability long-term 13,477 11,214 Total operating lease liabilities $ 14,885 $ 12,254 Total lease costs consist of the following: Lease costs Consolidated Statements of Operations Classification Three Months Ended October 31, 2020 Three Months Ended October 31, 2019 Nine Months Ended October 31, 2020 Nine Months Ended October 31, 2019 Finance Lease Costs Amortization of ROU assets Cost of sales $ 50 $ 53 $ 151 $ 155 Interest on lease liabilities Interest expense 17 18 54 36 Operating lease costs Cost of sales, SG&A expenses 682 579 1,904 1,716 Short-term lease costs (1) Cost of sales, SG&A expenses 53 140 289 401 Sub-lease income SG&A expenses (21 ) (20 ) (61 ) (61 ) Total Lease costs $ 781 $ 770 $ 2,337 $ 2,247 ( 1 Supplemental cash flow information related to leases is as follows: Nine Months Ended October 31, 2020 Nine Months Ended October 31, 2019 Cash paid for amounts included in the measurement of lease liabilities: Financing cash flows from finance leases $ 310 $ 185 Operating cash flows from finance leases 54 17 Operating cash flows from operating leases 1,713 1,127 Nine Months Ended October 31, 2020 ROU Assets obtained in exchange for new lease obligations: Finance leases liabilities $ - Operating leases liabilities 3,255 Weighted-average lease terms and discount rates are as follows: October 31, 2020 Weighted-average remaining lease terms (in years): Finance leases 2.5 Operating leases 12.9 Weighted-average discount rates: Finance leases 7.7 % Operating leases 7.9 % Maturities of lease liabilities as of October 31, 2020 Year: Operating Leases Finance Leases For the three months ended January 31, 2021 $ 630 $ 121 For the year ended January 31, 2022 2,360 328 For the year ended January 31, 2023 2,406 266 For the year ended January 31, 2024 2,392 143 For the year ended January 31, 2025 1,662 - For the year ended January 31, 2026 1,475 - Thereafter 14,339 - Total lease payments 25,264 858 Less: amount representing interest (10,379 ) (79 ) Total lease liabilities at October 31, 2020 $ 14,885 $ 779 Rent expense on operating leases, which is recorded on straight-line basis, was $0.7 $0.7 three October 31, 2020 2019 $2.2 $2.0 nine October 31, 2020 2019

Note 11 - Restricted Cash

Note 11 - Restricted Cash	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Cash and Cash Equivalents Disclosure [Text Block]	Note 11 Restricted cash held by foreign subsidiaries was $1.2 $1.1 October 31, 2020 2019 October 31, 2020 October 31, 2019 Cash and cash equivalents $ 6,593 $ 12,221 Restricted cash 1,154 1,138 Cash, cash equivalents and restricted cash shown in the statement of cash flows $ 7,747 $ 13,359

Note 12 - Fair Value

Note 12 - Fair Value	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 12 The carrying values of cash and cash equivalents, accounts receivable and accounts payable are reasonable estimates of their fair value due to their short-term nature. The carrying amount of the Company's short-term debt, revolving line of credit and long-term debt approximate fair value because the majority of the amounts outstanding accrue interest at variable market rates.

Note 13 - Recent Accounting Pro

Note 13 - Recent Accounting Pronouncements	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Description of New Accounting Pronouncements Not yet Adopted [Text Block]	Note 13 In March 2020, 2020 04, Reference Rate Reform 848 may December 31, 2021. not March 12, 2020 December 31, 2022. September 20, 2021 not In December 2019, 2019 12, Simplifying the Accounting for Income Taxes 740 December 15, 2020, In August 2018, 2018 14, Compensation - Retirement Benefits - Defined Benefit Plans - General 715 20 no December 15, 2020, 10 January 31, 2021 not In June 2016, No. 2016 13, Financial Instruments-Credit Losses 326 not December 15, 2019, December 15, 2022. The Company evaluated other recent accounting pronouncements and does not

Note 14 - Subsequent Events

Note 14 - Subsequent Events	9 Months Ended
	Oct. 31, 2020
Notes to Financial Statements
Subsequent Events [Text Block]	Note 14 As described in more detail in Note 9 December 17, 2020, 1.10 1.00 October 31, 2020 four

Note 4 - Revenue Recognition (T

Note 4 - Revenue Recognition (Tables)	9 Months Ended
	Oct. 31, 2020
Notes Tables
Disaggregation of Revenue [Table Text Block]	Three Months Ended October 31, Nine Months Ended October 31, 2020 2019 2020 2019 Sales % to Total Sales % to Total Sales % to Total Sales % to Total Products $ 2,435 12 % $ 2,448 7 % $ 8,603 14 % $ 13,205 14 % Specialty Piping Systems and Coating Revenue recognized under input method 8,252 41 % 14,363 42 % 26,597 42 % 38,601 40 % Revenue recognized under output method 9,607 47 % 17,646 51 % 28,199 44 % 43,594 46 % Total $ 20,294 100 % $ 34,457 100 % $ 63,399 100 % $ 95,400 100 %
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]	Contract Assets Balance January 31, 2019 $ 1,653 Costs and gross profit recognized during the period for uncompleted contracts from the prior period (1,038 ) Costs and deferred gross profit incurred on uncompleted contracts not billed at the end of the current period 1,368 Closing Balance at April 30, 2019 $ 1,983 Costs and gross profit recognized during the period for uncompleted contracts from the prior period (1,509 ) Costs and deferred gross profit incurred on uncompleted contracts not billed at the end of the current period 3,000 Closing Balance at July 31, 2019 $ 3,474 Costs and gross profit recognized during the period for uncompleted contracts from the prior period (1,799 ) Costs and deferred gross profit incurred on uncompleted contracts not billed at the end of the current period 2,688 Closing Balance at October 31, 2019 $ 4,363 Balance January 31, 2020 $ 2,166 Costs and gross profit recognized during the period for uncompleted contracts from the prior period (2,896 ) Costs and deferred gross profit incurred on uncompleted contracts not billed at the end of the current period 3,630 Closing Balance at April 30, 2020 $ 2,900 Costs and gross profit recognized during the period for uncompleted contracts from the prior period (1,743 ) Costs and deferred gross profit incurred on uncompleted contracts not billed at the end of the current period 593 Closing Balance at July 31, 2020 $ 1,750 Costs and gross profit recognized during the period for uncompleted contracts from the prior period (930 ) Costs and deferred gross profit incurred on uncompleted contracts not billed at the end of the current period 542 Closing Balance at October 31, 2020 $ 1,362 Contract Liabilities Balance January 31, 2019 $ 1,569 Revenue recognized during the period for uncompleted contracts from the prior period (444 ) New contracts entered into that are uncompleted at the end of the current period 721 Closing Balance at April 30, 2019 $ 1,846 Revenue recognized during the period for uncompleted contracts from the prior period (1,250 ) New contracts entered into that are uncompleted at the end of the current period 545 Closing Balance at July 31, 2019 $ 1,141 Revenue recognized during the period for uncompleted contracts from the prior period (774 ) New contracts entered into that are uncompleted at the end of the current period 984 Closing Balance at October 31, 2019 $ 1,351 Balance January 31, 2020 $ 1,173 Revenue recognized during the period for uncompleted contracts from the prior period (17 ) New contracts entered into that are uncompleted at the end of the current period (95 ) Closing Balance at April 30, 2020 $ 1,061 Revenue recognized during the period for uncompleted contracts from the prior period 631 New contracts entered into that are uncompleted at the end of the current period (925 ) Closing Balance at July 31, 2020 $ 767 Revenue recognized during the period for uncompleted contracts from the prior period 104 New contracts entered into that are uncompleted at the end of the current period (199 ) Closing Balance at October 31, 2020 $ 672

Note 6 - Impairment of Long-l_2

Note 6 - Impairment of Long-lived Assets (Tables)	9 Months Ended
	Oct. 31, 2020
Notes Tables
Schedule of Goodwill [Table Text Block]	January 31, 2020 Foreign exchange change effect October 31, 2020 Goodwill $ 2,254 $ (17 ) $ 2,237

Note 7 - Stock-based Compensa_2

Note 7 - Stock-based Compensation (Tables)	9 Months Ended
	Oct. 31, 2020
Notes Tables
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended October 31, Nine Months Ended October 31, 2020 2019 2020 2019 Stock-based compensation expense $ - $ 2 $ 3 $ 10 Restricted stock-based compensation expense 285 224 761 776 Total stock-based compensation expense $ 285 $ 226 $ 764 $ 786
Share-based Payment Arrangement, Option, Activity [Table Text Block]	Option activity No. of Shares Underlying Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 31, 2020 132 $ 8.98 3.2 $ 160 Expired or forfeited (18 ) - - - Outstanding at October 31, 2020 114 9.20 2.6 - Exercisable at October 31, 2020 114 $ 9.20 2.6 $ -
Schedule of Nonvested Share Activity [Table Text Block]	Unvested option activity No. of Shares Underlying Options Weighted Average Grant Date Fair Value Aggregate Intrinsic Value Outstanding at January 31, 2020 3 $ 7.33 $ 4 Vested (3 ) - - Expired or forfeited - - - Outstanding at October 31, 2020 - $ - $ -
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]	Restricted stock activity Restricted Shares Weighted Average Grant Price Per Share Aggregate Intrinsic Value Outstanding at January 31, 2020 321 $ 8.89 $ 2,857 Granted 156 5.88 Vested and issued (63 ) 8.96 Forfeited or retired for taxes (38 ) 8.20 Outstanding at October 31, 2020 376 $ 7.61 $ 2,857

Note 8 - Income_(Loss) Per Sh_2

Note 8 - Income/(Loss) Per Share (Tables)	9 Months Ended
	Oct. 31, 2020
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended October 31, Nine Months Ended October 31, 2020 2019 2020 2019 Basic weighted average common shares outstanding 8,165 8,037 8,113 7,970 Dilutive effect of equity compensation plans - - - 302 Weighted average common shares outstanding assuming full dilution 8,165 8,037 8,113 8,272 Stock options and restricted stock not included in the computation of diluted earnings per share of common stock because the option exercise prices or grant date prices exceeded the average market prices of the common shares 227 83 223 68 Stock options and restricted stock with exercise prices or grant date prices below the average market prices 165 287 169 302

Note 10 - Leases (Tables)

Note 10 - Leases (Tables)	9 Months Ended
	Oct. 31, 2020
Notes Tables
Supplemental Balance Sheet Information Related to Leases [Table Text Block]	Operating and Finance leases: October 31, 2020 January 31, 2020 Finance leases assets: Property and Equipment - gross $ 1,683 $ 1,696 Accumulated depreciation and amortization (700 ) (551 ) Property and Equipment - net $ 983 $ 1,145 Finance lease liabilities: Finance lease liability short-term $ 333 $ 417 Finance lease liability long-term 446 677 Total finance lease liabilities $ 779 $ 1,094 Operating lease assets: Operating lease ROU assets $ 13,762 $ 11,475 Operating lease liabilities: Operating lease liability short-term $ 1,408 $ 1,040 Operating lease liability long-term 13,477 11,214 Total operating lease liabilities $ 14,885 $ 12,254
Lease, Cost [Table Text Block]	Lease costs Consolidated Statements of Operations Classification Three Months Ended October 31, 2020 Three Months Ended October 31, 2019 Nine Months Ended October 31, 2020 Nine Months Ended October 31, 2019 Finance Lease Costs Amortization of ROU assets Cost of sales $ 50 $ 53 $ 151 $ 155 Interest on lease liabilities Interest expense 17 18 54 36 Operating lease costs Cost of sales, SG&A expenses 682 579 1,904 1,716 Short-term lease costs (1) Cost of sales, SG&A expenses 53 140 289 401 Sub-lease income SG&A expenses (21 ) (20 ) (61 ) (61 ) Total Lease costs $ 781 $ 770 $ 2,337 $ 2,247
Supplemental Cash Flow Information Related Leases [Table Text Block]	Nine Months Ended October 31, 2020 Nine Months Ended October 31, 2019 Cash paid for amounts included in the measurement of lease liabilities: Financing cash flows from finance leases $ 310 $ 185 Operating cash flows from finance leases 54 17 Operating cash flows from operating leases 1,713 1,127 Nine Months Ended October 31, 2020 ROU Assets obtained in exchange for new lease obligations: Finance leases liabilities $ - Operating leases liabilities 3,255
Weighted-average Lease Terms and Discount Rates [Table Text Block]	October 31, 2020 Weighted-average remaining lease terms (in years): Finance leases 2.5 Operating leases 12.9 Weighted-average discount rates: Finance leases 7.7 % Operating leases 7.9 %
Finance and Operating Lease, Liability, Maturity [Table Text Block]	Year: Operating Leases Finance Leases For the three months ended January 31, 2021 $ 630 $ 121 For the year ended January 31, 2022 2,360 328 For the year ended January 31, 2023 2,406 266 For the year ended January 31, 2024 2,392 143 For the year ended January 31, 2025 1,662 - For the year ended January 31, 2026 1,475 - Thereafter 14,339 - Total lease payments 25,264 858 Less: amount representing interest (10,379 ) (79 ) Total lease liabilities at October 31, 2020 $ 14,885 $ 779

Note 11 - Restricted Cash (Tabl

Note 11 - Restricted Cash (Tables)	9 Months Ended
	Oct. 31, 2020
Notes Tables
Restrictions on Cash and Cash Equivalents [Table Text Block]	October 31, 2020 October 31, 2019 Cash and cash equivalents $ 6,593 $ 12,221 Restricted cash 1,154 1,138 Cash, cash equivalents and restricted cash shown in the statement of cash flows $ 7,747 $ 13,359

Note 2 - Business Segment Rep_2

Note 2 - Business Segment Reporting (Details Textual)	9 Months Ended
	Oct. 31, 2020
Number of Reportable Segments	1

Note 3 - Accounts Receivable (D

Note 3 - Accounts Receivable (Details Textual) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Oct. 31, 2020USD ($)	Apr. 30, 2020USD ($)	Oct. 31, 2019	Oct. 31, 2020USD ($)	Oct. 31, 2019	Jan. 31, 2020USD ($)
Accounts Receivable, Outstanding for Several Years	$ 3,900			$ 3,900		$ 4,100
Retention Receivable	3,400			3,400
Accounts Receivable, Certified Invoices in Process of Collection		$ 500
Proceeds from Collection of Accounts Receivable Outstanding for Several Years	200
Allowance for Doubtful Accounts Receivable Outstanding for Several Years	$ 0			$ 0
Revenue Benchmark [Member] | Customer Concentration Risk [Member]
Number of Major Customers	0		1	0	1
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member]
Concentration Risk, Percentage			16.00%		11.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Number of Major Customers	1					1
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Customer [Member]
Concentration Risk, Percentage	10.10%					13.30%
Other Noncurrent Assets [Member]
Retention Receivable	$ 1,600			$ 1,600		$ 2,100

Note 4 - Revenue Recognition (D

Note 4 - Revenue Recognition (Details Textual) $ in Millions	3 Months Ended	9 Months Ended
	Oct. 31, 2020USD ($)	Oct. 31, 2020USD ($)
Costs Incurred for Uncompleted Contracts, Anticipated Collection Period (Year)		1 year
Middle East [Member]
Unbilled Receivables, Current	$ 1.4	$ 1.4
Other Nonoperating Income (Expense) [Member]
Expense Related to Encashment	$ 0.6	$ 0.6

Note 4 - Revenue Recognition -

Note 4 - Revenue Recognition - Revenues by Revenue Class (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Net sales	$ 20,294	$ 34,457	$ 63,399	$ 95,400
Sales by product, percent	100.00%	100.00%	100.00%	100.00%
Product [Member] | Transferred at Point in Time [Member]
Net sales	$ 2,435	$ 2,448	$ 8,603	$ 13,205
Sales by product, percent	12.00%	7.00%	14.00%	14.00%
Specialty Piping Systems And Coating [Member] | Transferred at Point in Time Using Input Method [Member]
Net sales	$ 8,252	$ 14,363	$ 26,597	$ 38,601
Sales by product, percent	41.00%	42.00%	42.00%	40.00%
Specialty Piping Systems And Coating [Member] | Transferred at Point in Time Using Output Method [Member]
Net sales	$ 9,607	$ 17,646	$ 28,199	$ 43,594
Sales by product, percent	47.00%	51.00%	44.00%	46.00%

Note 4 - Revenue Recognition _2

Note 4 - Revenue Recognition - Contract With Customer, Asset and Liability (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2020	Jul. 31, 2020	Apr. 30, 2020	Oct. 31, 2019	Jul. 31, 2019	Apr. 30, 2019
Balance, assets	$ 1,750	$ 2,900	$ 2,166	$ 3,474	$ 1,983	$ 1,653
Costs and gross profit recognized during the period for uncompleted contracts from the prior period	(930)	(1,743)	(2,896)	(1,799)	(1,509)	(1,038)
Costs and deferred gross profit incurred on uncompleted contracts not billed at the end of the current period	542	593	3,630	2,688	3,000	1,368
Balance, assets	1,362	1,750	2,900	4,363	3,474	1,983
Balance, liabilities	767	1,061	1,173	1,141	1,846	1,569
Revenue recognized during the period for uncompleted contracts from the prior period	104	631	(17)	(774)	(1,250)	(444)
New contracts entered into that are uncompleted at the end of the current period	(199)	(925)	(95)	984	545	721
Balance, liabilities	$ 672	$ 767	$ 1,061	$ 1,351	$ 1,141	$ 1,846

Note 5 - Income Taxes (Details

Note 5 - Income Taxes (Details Textual) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Effective Income Tax Rate Reconciliation, Percent, Total	0.80%	127.80%	6.20%	48.60%
Other Noncurrent Liabilities [Member]
Unrecognized Tax Benefits, Ending Balance	$ 0.1		$ 0.1

Note 6 - Impairment of Long-l_3

Note 6 - Impairment of Long-lived Assets (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Impairment of Long-Lived Assets Held-for-use	$ 0	$ 0	$ 0	$ 0
Goodwill, Impairment Loss	$ 0	$ 0	$ 0	$ 0

Note 6 - Impairment of Long-l_4

Note 6 - Impairment of Long-lived Assets - Goodwill (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2020USD ($)
Goodwill	$ 2,254
Goodwill, foreign exchange change effect	(17)
Goodwill	$ 2,237

Note 7 - Stock-based Compensa_3

Note 7 - Stock-based Compensation (Details Textual) $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 31, 2020USD ($)shares	Oct. 31, 2020USD ($)shares
Common Stock, Capital Shares Reserved for Future Issuance (in shares)	529,570	529,570
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance (in shares)	0	0
Share-based Payment Arrangement, Option [Member]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $	$ 0	$ 0
Restricted Stock [Member]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $	$ 1,600	$ 1,600
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)		1 year 328 days

Note 7 - Stock-based Compensa_4

Note 7 - Stock-based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Stock-based compensation expense	$ 285	$ 226	$ 764	$ 786
Share-based Payment Arrangement, Option [Member]
Stock-based compensation expense		2	3	10
Restricted Stock [Member]
Stock-based compensation expense	$ 285	$ 224	$ 761	$ 776

Note 7 - Stock-based Compensa_5

Note 7 - Stock-based Compensation - Stock Option Activity (Details) - Share-based Payment Arrangement, Option [Member] - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2020	Jan. 31, 2020
Outstanding at beginning of period (in shares)	132
Outstanding at beginning of period, weighted average exercise price (in dollars per share)	$ 8.98
Outstanding weighted average remaining contractual term (Year)	2 years 219 days	3 years 73 days
Outstanding at beginning of period, aggregate intrinsic value	$ 160
Expired or forfeited (in shares)	(18)
Expired or forfeited, weighted average exercise price (in dollars per share)
Outstanding at end of period (in shares)	114	132
Outstanding at end of period, weighted average exercise price (in dollars per share)	$ 9.20	$ 8.98
Outstanding at end of period, aggregate intrinsic value		$ 160
Exercisable at end of period (in shares)	114
Exercisable at end of period, weighted average exercise price (in dollars per share)	$ 9.20
Exercisable at end of period, weighted average remaining contractual term (Year)	2 years 219 days
Exercisable at end of period, aggregate intrinsic value

Note 7 - Stock-based Compensa_6

Note 7 - Stock-based Compensation - Unvested Option Activity (Details) - Unvested Option [Member] $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Oct. 31, 2020USD ($)$ / sharesshares
Outstanding at beginning of period (in shares)	3
Outstanding at beginning of period, weighted average exercise price (in dollars per share) | $ / shares	$ 7.33
Outstanding at beginning of period, aggregate intrinsic value | $	$ 4
Vested, number (in shares)	(3)
Expired or forfeited (in shares)
Expired or forfeited, weighted average exercise price (in dollars per share) | $ / shares
Outstanding at end of period (in shares)
Outstanding at end of period, weighted average exercise price (in dollars per share) | $ / shares
Outstanding at end of period, aggregate intrinsic value | $

Note 7 - Stock-based Compensa_7

Note 7 - Stock-based Compensation - Restricted Stock Activity (Details) - Restricted Stock [Member] $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Oct. 31, 2020USD ($)$ / sharesshares
Outstanding (unvested) at beginning of period (in shares) | shares	321
Outstanding (unvested) at beginning of period, weighted average grant price per share (in dollars per share) | $ / shares	$ 8.89
Outstanding (unvested) at beginning of period, aggregate intrinsic value | $	$ 2,857
Granted (in shares) | shares	156
Granted, weighted average grant price per share (in dollars per share) | $ / shares	$ 5.88
Vested and issued (in shares) | shares	(63)
Vested and issued, weighted average grant price per share (in dollars per share) | $ / shares	$ 8.96
Forfeited or retired for taxes (in shares) | shares	(38)
Forfeited or retired for taxes, weighted average grant price per share (in dollars per share) | $ / shares	$ 8.20
Outstanding (unvested) at endof period (in shares) | shares	376
Outstanding (unvested) at end of period, weighted average grant price per share (in dollars per share) | $ / shares	$ 7.61
Outstanding (unvested) at end of period, aggregate intrinsic value | $	$ 2,857

Note 8 - Income_(Loss) Per Sh_3

Note 8 - Income/(Loss) Per Share - Summary of Earnings Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Basic weighted average common shares outstanding (in shares)	8,165	8,037	8,113	7,970
Dilutive effect of equity compensation plans (in shares)				302
Weighted average common shares outstanding assuming full dilution (in shares)	8,165	8,037	8,113	8,272
Stock options and restricted stock not included in the computation of diluted earnings per share of common stock because the option exercise prices or grant date prices exceeded the average market prices of the common shares (in shares)	227	83	223	68
Stock options and restricted stock with exercise prices or grant date prices below the average market prices (in shares)	165	287	169	302

Note 9 - Debt (Details Textual)

Note 9 - Debt (Details Textual) $ in Thousands, د.إ in Millions, $ in Millions, ج.م. in Billions	Dec. 17, 2020USD ($)	May 01, 2020USD ($)	Sep. 20, 2018USD ($)	Jul. 28, 2016USD ($)	Jul. 28, 2016CAD ($)	Jun. 19, 2012USD ($)	Jan. 31, 2021	Jul. 31, 2020	Apr. 30, 2021	Jul. 31, 2021	Oct. 31, 2020USD ($)	Oct. 31, 2019USD ($)	Oct. 31, 2020USD ($)	Oct. 31, 2020AED (د.إ)	Jan. 31, 2020USD ($)	Nov. 30, 2019EGP (ج.م.)
Debt and Lease Obligation, Total											$ 9,700		$ 9,700		$ 16,900
Proceeds from Issuance of Long-term Debt, Total											19
Line of Credit, Current											$ 1,803		$ 1,803		$ 8,577
Revolving Lines, North America [Member]
Line of Credit Facility, Maximum Borrowing Capacity			$ 18,000
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage			0.375%
Line of Credit Facility, Capital Expenditures Restrictions			$ 3,000
Line of Credit Facility, Covenant Terms, EBITDA Ratio, Term One			1.1
Line of Credit Facility, Covenant Terms, EBITDA Ratio, Term Two			1.1
Line of Credit Facility, Covenant, Fixed Charge Coverage Ratio													1.1
Line of Credit Facility, Interest Rate at Period End											5.09%		5.09%	5.09%
Line of Credit Facility, Current Borrowing Capacity											$ 5,800		$ 5,800
Revolving Lines, North America [Member] | Foreign Subsidiaries [Member]
Line of Credit Facility, Cash Available to Satisfy a Future Potential Repatriation Cure of Ratio Covenant Breach											6,200		6,200
Revolving Lines, North America [Member] | Forecast [Member] | The Company and Its Subsidiaries [Member]
Line of Credit Facility, Fixed Charge Coverage Ratio Required									1.25	1.25
Revolving Lines, North America [Member] | Forecast [Member] | North American Loan Parties [Member]
Line of Credit Facility, Fixed Charge Coverage Ratio Required							1.1		1.1	1.1
Revolving Lines, North America [Member] | Subsequent Event [Member]
Repayments of Long-term Lines of Credit	$ 1,000
Line of Credit Facility, Additional Fees to Be Incurred	200
Line of Credit Facility, Maximum Borrowing Capacity, Availability Block	$ 2,000
Foreign Revolving Lines [Member]
Line of Credit Facility, Maximum Borrowing Capacity											$ 20,200		$ 20,200
Line of Credit Facility, Interest Rate at Period End											3.88%		3.88%	3.88%
Letters of Credit Outstanding, Amount											$ 4,500		$ 4,500
Proceeds from Issuance of Debt											1,000
Line of Credit Facility, Remaining Borrowing Capacity											$ 14,700		$ 14,700
Foreign Revolving Lines [Member] | Minimum [Member]
Line of Credit Facility, Interest Rate at Period End											3.70%		3.70%	3.70%
Debt Instrument, Interest Rate, Stated Percentage											4.50%		4.50%	4.50%
Foreign Revolving Lines [Member] | Maximum [Member]
Line of Credit Facility, Interest Rate at Period End											11.60%		11.60%	11.60%
Foreign Revolving Lines [Member] | EIBOR [Member] | Minimum [Member]
Debt Instrument, Basis Spread on Variable Rate											3.00%
Foreign Revolving Lines [Member] | EIBOR [Member] | Maximum [Member]
Debt Instrument, Basis Spread on Variable Rate											3.50%
Foreign Revolving Lines [Member] | CBE Corridor Rate [Member]
Debt Instrument, Basis Spread on Variable Rate											1.50%
Paycheck Protection Program CARES Act [Member]
Proceeds from Issuance of Long-term Debt, Total		$ 3,200
Percent of Proceeds from Issuance of Debt Used for Payroll Related Expenses								100.00%
Interest Rate 1 [Member] | Revolving Lines, North America [Member]
Line of Credit Facility, Interest Rate at Period End											6.25%		6.25%	6.25%
Interest Rate 2 [Member] | Revolving Lines, North America [Member]
Line of Credit Facility, Interest Rate at Period End											4.15%		4.15%	4.15%
Revolving Credit Lines Used by Middle Eastern Subsidiaries, 1 [Member] | Foreign Revolving Lines [Member]
Line of Credit Facility, Maximum Borrowing Capacity											$ 2,200		$ 2,200	د.إ 8.0
Line of Credit Facility, Interest Rate at Period End											3.70%		3.70%	3.70%
Revolving Credit Lines Used by Middle Eastern Subsidiaries, 2 [Member] | Foreign Revolving Lines [Member]
Line of Credit Facility, Maximum Borrowing Capacity											$ 5,300		$ 5,300	د.إ 19.5
Line of Credit Facility, Interest Rate at Period End											4.20%		4.20%	4.20%
Revolving Credit Lines Used by Middle Eastern Subsidiaries, 3 [Member] | Foreign Revolving Lines [Member]
Line of Credit Facility, Maximum Borrowing Capacity											$ 12,700		$ 12,700			ج.م. 0.2
Line of Credit Facility, Interest Rate at Period End																11.60%
Canadian Mortgage Note [Member]
Proceeds from Issuance of Debt				$ 6,100	$ 8
Debt Instrument, Maturity Date				Dec. 23, 2042	Dec. 23, 2042
Debt Instrument, Interest Rate, Effective Percentage											4.55%		4.55%	4.55%
Mortgage Note Secured by Tennessee Manufacturing Facility [Member]
Debt Instrument, Interest Rate, Stated Percentage						4.50%
Debt Instrument, Maturity Date						Jul. 1, 2027
Debt Instrument, Issuance Date						Jun. 19, 2012
Proceeds from Issuance of Secured Debt						$ 1,800
Debt Instrument, Periodic Payment, Total						$ 13
Debt Instrument, Adjustable Interest Rate Period, Commencement Date						Jun. 19, 2022
Debt Instrument, Interest Rate, Maximum Annual Increase						2.00%
Debt Instrument, Adjustable Interest Rate, Ceiling						18.00%
Debt Instrument, Adjustable Interest Rate, Floor						4.50%

Note 10 - Leases (Details Textu

Note 10 - Leases (Details Textual) $ in Thousands, ₨ in Millions, د.إ in Millions, $ in Millions	Aug. 05, 2016USD ($)	Oct. 31, 2020USD ($)	Oct. 31, 2020AED (د.إ)	Oct. 31, 2019USD ($)	Oct. 31, 2020USD ($)	Oct. 31, 2019USD ($)	Jan. 31, 2020USD ($)	Jan. 31, 2018USD ($)	Jan. 31, 2020CAD ($)	Jan. 31, 2018CAD ($)	Aug. 05, 2016INR (₨)
Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total		$ 1,000			$ 1,000
Operating Lease, Liability, Total		14,885			14,885		$ 12,254
Operating Lease, Right-of-Use Asset		13,762			13,762		11,475
Finance Lease, Liability, Total		779			779		1,094
Operating Lease, Expense		$ 700		$ 700	$ 2,200	$ 2,000
Maximum [Member]
Lessee, Operating Lease, Term of Contract (Year)		14 years			14 years
Minimum [Member]
Lessee, Operating Lease, Term of Contract (Year)		1 year			1 year
Finance Vehicle Equipment, One [Member]
Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total							$ 800	$ 800	$ 1.1	$ 1.1
Interest Rate for Finance Lease							8.00%
Finance Vehicle Equipment, One [Member] | Maximum [Member]
Interest Rate for Finance Lease								7.80%
Finance Lease, Principal Payments and Interest Payment on Liability							$ 100	$ 100
Finance Vehicle Equipment, One [Member] | Minimum [Member]
Interest Rate for Finance Lease								4.00%
Finance Vehicle Equipment, Two [Member]
Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total	$ 8										₨ 0.6
Interest Rate for Finance Lease	15.60%
Finance Vehicle Equipment, Two [Member] | Maximum [Member]
Finance Lease, Principal Payments and Interest Payment on Liability	$ 1
Abu Dhabi Land Lease [Member]
Lessee, Operating Lease, Annual Payment		$ 300	د.إ 1.2

Note 10 - Leases - Supplemental

Note 10 - Leases - Supplemental Balance Sheet Information Related to Leases (Details) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Property and Equipment - net	$ 26,958	$ 28,629
Finance lease liability short-term	333	417
Finance lease liability long-term	446	677
Total finance lease liabilities	779	1,094
Operating Lease, Right-of-Use Asset	13,762	11,475
Operating lease liability short-term	1,408	1,040
Operating lease liability long-term	13,477	11,214
Total operating lease liabilities	14,885	12,254
Finance Leases Assets [Member]
Property and Equipment - gross	1,683	1,696
Accumulated depreciation and amortization	(700)	(551)
Property and Equipment - net	$ 983	$ 1,145

Note 10 - Leases - Lease Costs

Note 10 - Leases - Lease Costs (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Amortization of ROU assets		$ 50	$ 53	$ 151	$ 155
Interest on lease liabilities		17	18	54	36
Operating lease costs		682	579	1,904	1,716
Short-term lease costs (1)	[1]	53	140	289	401
Sub-lease income		(21)	(20)	(61)	(61)
Total Lease costs		$ 781	$ 770	$ 2,337	$ 2,247
[1]	Includes variable lease costs, which are immaterial

Note 10 - Leases - Supplement_2

Note 10 - Leases - Supplemental Cash Flow Information Related to Leases (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Financing cash flows from finance leases	$ 310	$ 185
Operating cash flows from finance leases	54	17
Operating cash flows from operating leases	1,713	$ 1,127
Finance leases liabilities
Operating leases liabilities	$ 3,255

Note 10 - Leases - Weighted-ave

Note 10 - Leases - Weighted-average Lease Terms and Discount Rates (Details)	Oct. 31, 2020
Finance leases (Year)	2 years 182 days
Operating leases (Year)	12 years 328 days
Finance leases	7.70%
Operating leases	7.90%

Note 10 - Leases - Maturities o

Note 10 - Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
For the three months ended January 31, 2021For the year ended January 31, 2026, operating leases, operating leases	$ 630
For the three months ended January 31, 2021	121
For the year ended January 31, 2022For the year ended January 31, 2026, operating leases, operating leases	2,360
For the year ended January 31, 2022	328
For the year ended January 31, 2023For the year ended January 31, 2026, operating leases, operating leases	2,406
For the year ended January 31, 2023	266
For the year ended January 31, 2024For the year ended January 31, 2026, operating leases, operating leases	2,392
For the year ended January 31, 2024	143
For the year ended January 31, 2025For the year ended January 31, 2026, operating leases, operating leases	1,662
For the year ended January 31, 2025
For the year ended January 31, 2026, operating leases, operating leases	1,475
For the year ended January 31, 2026
Thereafter, operating leases	14,339
Thereafter
Total lease payments, operating leases	25,264
Total lease payments, finance leases	858
Less: amount representing interest, operating leases	(10,379)
Less: amount representing interest, finance leases	(79)
Total lease liabilities, operating leases	14,885	$ 12,254
Total lease liabilities, finance leases	$ 779	$ 1,094

Note 11 - Restricted Cash (Deta

Note 11 - Restricted Cash (Details Textual) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020	Oct. 31, 2019
Restricted Cash, Current	$ 1,154	$ 1,287	$ 1,138
Non-US [Member]
Restricted Cash, Current	$ 1,200		$ 1,100

Note 11 - Restricted Cash - Sum

Note 11 - Restricted Cash - Summary of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020	Oct. 31, 2019
Cash and cash equivalents	$ 6,593	$ 13,371	$ 12,221
Restricted cash	1,154	$ 1,287	1,138
Cash, cash equivalents and restricted cash shown in the statement of cash flows	$ 7,747		$ 13,359

Note 14 - Subsequent Events (De

Note 14 - Subsequent Events (Details Textual)	12 Months Ended
	Oct. 31, 2020
Revolving Lines, North America [Member]
Line of Credit Facility, Covenant, Fixed Charge Coverage Ratio	1.1